The University of Chicago Header Logo

Connection

Marina Chiara Garassino to International Agencies

Back to Details
This is a "connection" page, showing publications Marina Chiara Garassino has written about International Agencies.
Marina Chiara Garassino
Connection Strength
0.043
International Agencies
  1. Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Ann Oncol. 2019 02 01; 30(2):161-165.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.